Skip to content

GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance

GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance : GERABEL Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02994914
Acronym
GERABEL
Enrollment
241
Registered
2016-12-16
Start date
2016-12-05
Completion date
2020-06-26
Last updated
2022-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast Cancer, Onco Geriatric Evaluation, Radiotherapy, Hypo fractionated radiotherapy, Normo fractionated radiotherapy, Large hypo fractionated radiotherapy

Brief summary

This study proposes an onco geriatric evaluation (Activities of Daily Living, Instrumental Activities Of Daily Living, Mini Mental State Examination, mini Geriatric Depression Scale, Mini Nutritional Assessment, Cumulative Illness Rating Scale-Geriatric, and timed get up and go tests) for elderly breast cancer patients. The score obtained at this evaluation will determine the radiotherapy scheme.

Detailed description

Breast cancer is the most frequent cancer for elderly women and represents the first mortality cause for them. Breast cancer incidence increases for elderly women and will become a major public health problem in the next years. The principal therapeutic solution is the partial mastectomy associated to radiotherapy. However, the radiotherapy scheme and its role are debated for elderly patients. Hypo fractionated radiotherapy could be considered as an advantageous option. The treatment duration (6,5 weeks) and direct and indirect fatigue (around 33 travels) are major cons. Thereby, for elderly patients, the selection of patients who will benefit from a shorter treatment could be really difficult. It would be interesting to define an objective scoring, predicting a bad or good tolerance and observance to the radiotherapy. Nowadays, onco geriatric evaluations are used to decide some treatment's decision, but no study compared different orientated radiotherapy schemes. The present study proposes an onco geriatric evaluation leading to a score according to seven tests (Activities of Daily Living, Instrumental Activities Of Daily Living, Mini Mental State Examination, mini Geriatric Depression Scale, Mini Nutritional Assessment, Cumulative Illness Rating Scale-Geriatric, and timed get up and go tests). The score will then determine an adapted radiotherapy scheme.

Interventions

OTHEROnco Geriatric Evaluation

Seven tests will be performed by an onco geriatrician : Activities of Daily Living, Instrumental Activities Of Daily Living, Mini Mental State Examination, mini Geriatric Depression Scale, Mini Nutritional Assessment, Cumulative Illness Rating Scale-Geriatric, and timed get up and go tests. Those tests lead to a score, and this score will determine the scheme of patients radiotherapy.

Sponsors

Centre Antoine Lacassagne
CollaboratorOTHER
Institut de Cancérologie de la Loire
CollaboratorOTHER
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Woman more than 70 years old, * Patient carrying a breast cancer proven histologically and treated by radiotherapy in curative intent.

Exclusion criteria

* Man, * Patient with metastatic cancer, * Patient with impossible follow-up at 6 months (planned relocation, patient support in another Center), * Patient under protection of justice or unable to give consent.

Design outcomes

Primary

MeasureTime frameDescription
Measure of the toleranceMonth 6Tolerance is considered as bad if the score of the onco geriatric evaluation decreases of more than 20% from the initial evaluation to 6 months after the end of the rays. Tolerance is considered as correct in the other cases.

Secondary

MeasureTime frameDescription
Quality of Life QuestionnaireMonth 6Quality of life will be assessed with the difference between the Quality of Life Questionnaire 30 of the European Organisation for Research and Treatment of Cancer (EORTC) score obtained before the radiotherapy and 6 months after the end of the radiation therapy.
Radiotherapy complianceMonth 6Compliance is considered as bad if the treatment plan is interrupted for at least one day (for medical reason). Compliance is considered as correct in the other cases.
Correlation between tolerance and distance from the therapeutic centerMonth 6Correlation will potentially be established between patient general tolerance and the distance between home and radio therapeutic center.
ToleranceMonth 6Specific tolerance will be evaluated by the number of radiation-induced toxicities (Common Terminology Criteria for Adverse Events 4.4) of I, II, III, and IV grades.
Correlation between tolerance and the number of concomitant treatmentsMonth 6Correlation will potentially be established between patient general tolerance and the number of concomitant treatments.
Correlation between tolerance and the nature of concomitant treatmentsMonth 6Correlation will potentially be established between patient general tolerance and the nature of concomitant treatments.
Correlation between tolerance and the supportive caresMonth 6Correlation will potentially be established between patient general tolerance and the supportive cares performed.
Correlation between tolerance and way of transportMonth 6Correlation will potentially be established between patient general tolerance and the way of transport used by the patient to go to the therapeutic center.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026